BRIEF published on 03/02/2026 at 13:40, 1 month 20 days ago CPHI & PMEC China 2026 Set to Return to Shanghai This June Innovation Pharma Industry Pharmaceutical Event CPHI & PMEC China Shanghai 2026
PRESS RELEASE published on 03/02/2026 at 13:35, 1 month 20 days ago The largest pharma show in Asia makes its return to Shanghai this June 2026 CPHI & PMEC China 2026, the largest pharma show in Asia, returns to Shanghai in June with over 110,000 attendees and 3,600 exhibitors showcasing pharmaceutical solutions and innovations Innovation Asia Shanghai CPHI & PMEC China Pharma Show
Published on 04/22/2026 at 13:30, 37 minutes ago ZTEST Electronics Inc. Announces Its Intention to Effect a Normal Course Issuer Bid
Published on 04/22/2026 at 13:00, 1 hour 7 minutes ago AmeriTrust Announces 2025 Annual Financial Results
Published on 04/22/2026 at 13:00, 1 hour 7 minutes ago Kalo Gold Defines Kilometre-Scale Epithermal Gold Targets and Structural Corridors at Wainikoro Within a 40 km Gold Corridor, Vatu Aurum, Fiji
Published on 04/22/2026 at 13:55, 11 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Consolidated Financial Statements, Dividend Proposal and Guidance
Published on 04/22/2026 at 13:55, 12 minutes ago Banyan Group Releases 2025 Sustainability Report, Marking 20 Years of Reporting and 100-Property Milestone
Published on 04/22/2026 at 13:40, 26 minutes ago EQS-Adhoc: Rejection of appeal against the revocation of the admission of ZhongDe Waste Technology AG shares to trading on the regulated market (General Standard)
Published on 04/22/2026 at 13:35, 32 minutes ago DeFi Technologies' Asset Management Business, Valour, Secures US$11 Million in Institutional Investment into Hedera ETPs, Including US$10 Million on Börse Frankfurt and US$1 Million on Sweden's Spotlight
Published on 04/22/2026 at 13:05, 1 hour 2 minutes ago EQS-Adhoc: ad pepper media International N.V.: Strongest first quarter in over 25 years of company history, EBITDA between EUR 6.5 and EUR 7.5 million expected for 2026
Published on 04/22/2026 at 07:00, 7 hours 7 minutes ago Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/21/2026 at 19:15, 18 hours 52 minutes ago AXA - Description of the Company’s share repurchase program
Published on 04/21/2026 at 18:00, 20 hours 7 minutes ago Outstanding shares and voting rights statement at 31 March 2026
